BG Medicine Announces One-for-Four Reverse Stock Split By: Benzinga via Benzinga July 08, 2015 at 17:00 PM EDT BG Medicine, Inc. (Nasdaq: BGMD), the developer of the BGM Galectin-3® Test, today announced the effectiveness of a one-for-four reverse ... Read More >>